Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309616 | 0.85 | ALDH1A1 (0.49) | CYP1A2CYP2C9CYP2C19ATMNPSR1 | |
| SCHEMBL23309607 | 0.85 | MAPT (0.49) | NPSR1MAPTTP53KMT2AMEN1 | |
| SCHEMBL23309722 | 0.82 | POLB (0.45) | CYP1A2MAPTTP53THRBKMT2A | |
| SCHEMBL23309666 | 0.81 | ALDH1A1 (0.52) | MAPTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL23309534 | 0.79 | L3MBTL1 (0.51) | CYP1A2CYP2C9CYP2C19NPSR1MAPT | |
| SCHEMBL23309708 | 0.73 | RAB9A (0.52) | HTTKMT2ASMN1; SMN2 | |
| SCHEMBL23309619 | 0.73 | NPC1 (0.40) | CYP1A2CYP2C9CYP2C19ATMNPSR1 | |
| SCHEMBL9394319 | 0.70 | HPGD (0.55) | HTTCYP1A2CYP2C9CYP2C19ATM | |
| SCHEMBL23309544 | 0.69 | TSHR (0.48) | HTTCYP1A2CYP2C9CYP2C19NPSR1 | |
| SCHEMBL23309542 | 0.69 | CA12 (0.42) | CYP1A2CYP2C9CYP2C19MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | HTT 2558/4885CYP1A2 1133/4885CYP2C9 1774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.